NCT04848337: Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer
- State
- Under way
- Phase
- Phase 2
- People
- 45 taking part
- Started
- 25 May 2021
- Primary completion
- 8 Jan 2025
- Arms
- Study Treatment Arm
- Results
- Posted on the registry
- 19 Apr 2021: Trial registered
- 25 May 2021: Trial started
- 12 Feb 2026: Trial results posted